EUVIMEDEUVIMED entdecken
Crossref

Molecular Subtypes in Acute Respiratory Illness and Sepsis

Philip A Efron, Brendon P Scicluna iD

Seminars in Respiratory and Critical Care Medicine · 27.10.2026

DOI: 10.1055/a-2984-4603 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Seminars in Respiratory and Critical Care Medicine, erschienen am 27.10.2026. Verfasst von Philip A Efron und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of Florida College of Medicine, Department of Surgery and Sepsis and Critical Illness Research Center, Florida, United States, Gainesville.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sepsis and acute respiratory illness are clinical syndromes that encompass profound biological heterogeneity. The resulting heterogeneity of treatment effect is now widely understood as the explanation to why immunomodulatory trials in critical care have not me their study endpoints, thereby misclassifying effective therapies as futile while concealing harm in biologically ineligible subgroups. High-dimensional molecular profiling offers a route to resolve this heterogeneity into tractable subgroups or subtypes. Here we review molecular subtypes across adult and paediatric sepsis, pneumonia, and acute respiratory distress syndrome (ARDS), spanning transcriptomic, proteomic, metabolomic, and lipidomic platforms. Blood transcriptomic frameworks derived independently in multiple countries, and subsequently harmonized by international consensus efforts, converge on recurring immune archetypes: a myeloid inflammatory state dominated by neutrophil activation; a mixed myeloid and lymphoid dysregulated state carrying the highest mortality; and a relatively immunocompetent state with preserved lymphocyte function and the most favourable clinical trajectory. Plasma proteomic and metabolomic profiling recapitulate this architecture at orthogonal molecular layers, arguing that these archetypes are platform-independent rather than artefacts of any single technology. Cross-syndrome convergence is asymmetric, which plausibly reflects the methodological differences between top-down latent class analysis in ARDS and bottom-up unsupervised clustering in sepsis. Secondary analyses of randomized controlled trials consistently show subtype-dependent responses to treatment strategies, with a coherent directionality with potential benefit in hyperinflammatory states, and harm in immunosuppressed or adaptive immune-prevalent states. Subtype membership is not static; trajectory, not baseline assignment, most strongly encodes prognosis. Realising precision critical care now requires prospective, subtype-stratified trials of which none has yet been completed.

Autor:innen und Institutionen

  • University of Florida College of Medicine, Department of Surgery and Sepsis and Critical Illness Research Center, Florida, United States, Gainesville.
  • University of Malta, Department of Applied Biomedical Science, Faculty of Health Sciences, Mater Dei hospital, Malta, Msida.
  • University of Malta, Centre for Molecular Medicine and Biobanking, Biomedical Sciences, Malta, Msida.

ORCID-Profile: Brendon P Scicluna

Zitieren

APA

Efron, P. A., & Scicluna, B. P. (2026). Molecular Subtypes in Acute Respiratory Illness and Sepsis. Seminars in Respiratory and Critical Care Medicine. https://doi.org/10.1055/a-2984-4603

Vancouver

Efron PA, Scicluna BP. Molecular Subtypes in Acute Respiratory Illness and Sepsis. Seminars in Respiratory and Critical Care Medicine. 2026. doi:10.1055/a-2984-4603

BibTeX
@article{Efron2026,
  author = {Efron, Philip A and Scicluna, Brendon P},
  title = {Molecular Subtypes in Acute Respiratory Illness and Sepsis},
  journal = {Seminars in Respiratory and Critical Care Medicine},
  year = {2026},
  doi = {10.1055/a-2984-4603}
}
Kostenlos starten →